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AbstrACt
Objective Understanding the factors that influence 
human papillomavirus (HPV) vaccination uptake is 
critically important to the design of effective vaccination 
programmes. In Switzerland, HPV vaccination uptake 
(≥1 dose) by age 16 years among women ranges from 
31% to 80% across 26 cantons (states). Our objective 
was to identify factors that are associated with the spatial 
variation in HPV vaccination uptake.
Methods We used cross-sectional data from the Swiss 
National Vaccination Coverage Survey 2009–2016 on HPV 
vaccination status (≥1 dose) of 14–17-year-old girls, their 
municipality of residence and their nationality for 21 of 26 
cantons (n=8965). We examined covariates at municipality 
level: language, degree of urbanisation, socioeconomic 
position, religious denomination, results of a vote about 
vaccination laws as a proxy for vaccine scepticism and, 
at cantonal level, availability of school-based vaccination 
and survey period. We used a series of conditional 
autoregressive models to assess the effects of covariates 
while accounting for variability between cantons and 
municipal-level spatial autocorrelation.
results In the best-fit model, living in cantons that 
have school-based vaccination (adjusted OR 2.51; 95% 
credible interval 1.77 to 3.56) was associated with 
increased uptake, while living in municipalities with lower 
acceptance of vaccination laws was associated with lower 
HPV vaccination uptake (OR 0.61; 95% credible interval 
0.50 to 0.73). Overall, the covariates explained 88% of the 
municipal-level variation in uptake.
Conclusions In Switzerland, both cantons and community 
opinion about vaccination play a prominent role in the 
variation in HPV vaccination uptake. To increase uptake, 
efforts should be made to mitigate vaccination scepticism 
and to encourage school-based vaccination.
IntrOduCtIOn
Human papillomavirus (HPV) is the most 
common viral infection of the reproductive 
tract.1 Persistent infections with HPV types 
16 and 18 are responsible for 70% of cervical 
cancers and precancerous cervical lesions.1 
Genital HPV types also cause anogenital 
warts and cancers of the anus, vulva, vagina 
and penis.1 In 2006, the first vaccine against 
HPV was licensed and, by 2016, at least 68 
countries had implemented vaccination 
programmes for the prevention of cervical 
cancer in at least one region.2 Optimal HPV 
vaccination coverage (full-dose schedule) 
is estimated to be around 70% for women 
but there are large geographical disparities 
in vaccination coverage between and within 
countries.2 3 The UK and Australia have 
reached homogeneous levels of around 70% 
vaccination coverage.4–6 In contrast, many 
countries including Italy, France, Switzer-
land, Germany, the Netherlands and the USA 
experience lower national coverage rates with 
large regional variations.7–11 
There are several challenges to achieving 
high levels of HPV vaccine coverage, such 
as concerns that it might promote risky 
strengths and limitations of the study
 ► We used individual-level data from a national vacci-
nation coverage survey covering more than 90% of 
the Swiss population during the evolution of human 
papillomavirus vaccination programmes from 2009 
to 2016.
 ► We adjusted for spatial confounding using Besag-
York-Mollié conditional autoregressive models.
 ► We used the outcome of a popular referendum 
against a revised epidemic law as a proxy measure 
of vaccine scepticism.
 ► The survey sampling methods and response rates 
differed across cantons (states).
 ► Five out of 26 cantons did not participate in the 
study.
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sexual behaviour in adolescents and logistical issues 
about reaching adolescents.12 Individuals shape the 
geographic and social contexts in which they live, but 
their behaviour is also affected by their context.13 An 
understanding of community-level and individual-level 
factors associated with HPV vaccination uptake is there-
fore important. It has been shown that countries with 
extensive school-based vaccination reached markedly 
higher uptake rates.14 Conversely, lower levels of HPV 
vaccine uptake have been found in communities or 
states with high levels of votes for religious or conser-
vative parties,11 15 but it is not known how closely these 
reflect attitudes towards vaccination. At the individual 
level, findings about factors such as socioeconomic posi-
tion (SEP), ethnicity or religious affiliation are more 
mixed.8 11 16–22 For example, poverty, based on either 
low income or SEP, has been found to be associated 
with both lower11 16 19 20 23–26 and higher HPV vaccina-
tion uptake.18 20 21 27 Furthermore, few studies have 
accounted for spatial autocorrelation due to unknown 
confounding.16 17 22 Neglecting this spatial autocorrela-
tion can lead to spurious associations.28
Switzerland provides a valuable setting for inves-
tigating regional differences in vaccine uptake. The 
country is spatially divided into 26 cantons (states) and 
four language regions (German, French, Italian and 
Romansh). The cantons have a high degree of autonomy 
with devolved administration of health and education. 
Within cantons, municipalities also enjoy a high level of 
autonomy including the power to pass municipal laws. 
People vote regularly in referendums on a wide range of 
issues that then determine legislation. All Swiss cantons 
implemented HPV vaccination programmes by the end 
of 2008, targeting 11–14-year-old girls for basic vacci-
nation and additionally including young women and 
men (up to 26 years old) for complementary vaccina-
tion. A two-dose vaccination schedule (administered 
at 0 and 6 months) was introduced in 2012, replacing 
the earlier three-dose schedule. The HPV basic vacci-
nation programmes for school-aged girls differ widely 
between cantons, ranging from the simple distribution 
of educational material, informing parents that vacci-
nation is available, through to school-based vaccination 
delivery.29–31
The objective of this study was to investigate the spatial 
heterogeneity of HPV vaccination uptake in Switzer-
land, and to identify factors at different spatial levels that 
explain this variation. We investigated both political and 
cultural contextual factors. We hypothesised that the 
canton of residence would represent an important contex-
tual factor influencing whether or not an individual girl 
had received HPV vaccination. We further expected that 
covariates at the level of the municipality, such as the 
degree of political scepticism about vaccination, socio-
economic status, language, religion or the level of urban-
isation, could represent important contextual factors that 
play a role in explaining differences in uptake.
MethOds
We conducted a multilevel spatial analysis of the Swiss 
National Vaccination Coverage Survey (SNVCS).32–34 We 
used a series of Bayesian hierarchical logistic regression 
models that include spatial autocorrelation, a random 
effect to account for variability between the cantons, and 
several covariates.
Individual-level data
We used data from the SNVCS, which is a national cross-sec-
tional survey that monitors immunisation coverage of chil-
dren and adolescents.32–34 This survey has been designed 
to be representative of the Swiss population with respect 
to key demographic characteristics.34 The Swiss Federal 
Office of Public Health mandates the Epidemiology, 
Biostatistics and Prevention Institute (EPBI, University 
of Zurich, Switzerland) to collate data in 3-year cycles 
from all cantons in surveys organised either by EBPI or 
by the individual cantons. Three different cross-sectional 
sampling methods were used: cluster sampling (munici-
palities), simple random sampling or information collec-
tion by school nurses (see online supplementary table 1). 
The methodology is described in detail elsewhere.34 For 
cluster sampling and simple random sampling, the parents 
of 16-year-old girls received an invitation (by email or by 
phone) and were asked to send a copy of the daughter’s 
vaccination card. In three cantons, school nurses recorded 
the information at health checkup days for 14–16-year-old 
girls. We used anonymised, individual-level information 
about HPV vaccination status (having received at least 
one dose of HPV vaccine), nationality (Swiss or non-Swiss, 
coded as 0 and 1, respectively) and municipality of resi-
dence. Hence, vaccination coverage refers to vaccina-
tion initiation and not the completed full-dose schedule. 
Missing individual information about nationality was 
replaced with the proportion of non-Swiss people in the 
subject’s municipality of residence based on the national 
census in 2013.35
Covariates at municipality and cantonal level
At the cantonal level, we considered survey period 
(2008–2010, 2011–2013, 2014–2016, excluding 2008 
because not all cantons had implemented their vaccina-
tion programme at the time) and availability of school-
based HPV vaccination delivery (defined as provision by 
at least one school in the canton, yes, no).36 At the munic-
ipality level, we considered language region (French, 
German or Italian),37 majority religious denomination 
(≥50% catholic,≥50% protestant or neither),38 SEP (mean 
Swiss SEP, a neighbourhood-based measure of with lower 
values indicating lower SEP39 40) and level of urbanisa-
tion (rural, semiurban, urban, based on standard Swiss 
classifications37).
We also considered the municipality-level results of a 
popular referendum in 2013 as a proxy measure of vaccine 
scepticism.41 42 The referendum was proposed by oppo-
nents of a revision to a national law about the control of 
epidemics, which included new recommendations about 
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vaccination (see online supplementary material, section 
1, page 3). We calculated the percentage of votes in favour 
of revision of the law for each municipality. We considered 
municipalities with a low percentage of people in favour 
of the revised law as having higher proportions of people 
who are sceptical about vaccination than municipalities 
that strongly favoured the revised law. For the continuous 
variables, referendum results and the Swiss SEP index, 
we generated quartiles and compared the lowest and the 
highest quartiles with the second and third (baseline) 
quartiles to capture possible effects of more extreme 
values. Most municipality-level variables were retrieved 
from publicly available data from the Swiss Federal Statis-
tical Office for 2012 and 2013. Data on religious denom-
ination and Swiss SEP were based on the year 2000. A 
more detailed description of the variables is given in the 
online supplementary material, section 1, figure 1–6 and 
table 2.
The SNVCS has received ethical committee approval. 
According to the Swiss Human Research Act (Art.2.2 
al.c.), additional ethical committee review for this study 
was not required because anonymised health-related data 
were used.
statistical analysis
We developed Bayesian hierarchical logistic regression 
models to investigate the spatial heterogeneity of HPV 
vaccination uptake across municipalities (table 1). First, 
we fitted a model that captures spatial variation at the 
municipality level (model 1). Spatial autocorrelation was 
modelled using the Besag-York-Mollié (BYM) conditional 
autoregressive prior distribution.43 For municipalities 
not sampled by the survey, BYM borrows information 
about the uptake from the neighbouring municipalities. 
Second, we added a random effect at the cantonal level 
(model 2) to test the hypothesis that cantons represent an 
important contextual factor for HPV vaccination uptake. 
Third, we additionally included all covariates (model 3, 
‘full model’) and calculated the percentage of munic-
ipal variation explained by the cantonal random effect 
and the covariates. To do this, we calculated the median 
posterior variance of the municipal random effect (sum 
of spatially correlated and uncorrelated component) in 
each of these models and the percentage reduction of 
this variance in models 2 and 3 compared with model 1.
To examine the effect of the prespecified covariates, we 
performed model selection using the deviance informa-
tion criterion (DIC).44 In addition to models 1–3, we ran 
four alternative models that only included the municipal 
random effect and the covariates (model 4), the cantonal 
random effect (model 5), the cantonal random effect 
and the covariates (model 6) and the covariates only 
(model 7). We also examined the univariable association 
with each of the eight covariates (model 8). We present 
the univariable associations (model 8), a fully adjusted 
logit model excluding random effects (model 7) and 
the model from 1 to 7 with the smallest DIC. We present 
results as median OR with 95% credible intervals.
We conducted three sensitivity analyses. First, we exam-
ined whether the non-respondents differ from respon-
dents with respect to the covariates. Second, we compared 
results of the main analysis with models that assumed that 
all non-respondents were vaccinated, or that all non-re-
spondents were not vaccinated. Third, we examined 
whether the survey sampling method affected the results 
by including sampling method as a covariate in the model 
with the smallest DIC.
Inference was performed using the Integrated Nested 
Laplace Approximation for latent Gaussian models.45 
Further details about the different models, their imple-
mentation and the sensitivity analyses are provided in the 
online supplementary material (sections 2 and 3).
results
We analysed data from 21 of 26 cantons (91.1% of the 
Swiss population, see online supplementary table 1).
data characteristics
We analysed data from 8965 out of 14 106 sampled girls 
from the participating cantons. We excluded 2056 indi-
viduals sampled in 2008, 3072 individuals who did not 
respond and 13 individuals with missing information 
about municipality of residence. The average response 
rate was 75.1% and ranged from 39.9% to 92.1% between 
cantons (see online supplementary figure 7 and table 
1). Among the included participants, data on nationality 
were missing in 11.7% (1051/8965), concentrated in four 
cantons (see online supplementary material, section 1). 
The average vaccination uptake in survey participants from 
the 21 cantons and over all survey periods was 53.2% (95% 
Table 1 Comparison of Bayesian hierarchical logistic 
regression models that explain the spatial heterogeneity of 
HPV vaccination uptake in Switzerland
Model type
Spatial 
component
Cantonal 
random 
effect Covariates* DIC
Model 1
(BYM unadjusted)
X 11 513
Model 2
(BYM cantonal)
X X 11 489
Model 3 (full) X X X 11 417
Model 4 X X 11 432
Model 5 X 11 541
Model 6 X X 11 450
Model 7
(logit model)
X 11 557
Model 8† 
(univariable) 
X –
*Nationality, urbanisation level, Swiss socioeconomic position, 
political opinion, religious denominations, language region, school-
based human papillomavirus vaccination programme, survey 
period.
†Model 8 (univariable) was adjusted for one variable at time.
BYM, Besag-York-Mollié prior; DIC, deviance information criterion.
4 Riesen M, et al. BMJ Open 2018;8:e021006. doi:10.1136/bmjopen-2017-021006
Open Access 
CI 46.8%  to 59.7%) but varied greatly between cantons 
(figure 1). Seventy per cent of included girls in the survey 
were Swiss, 66% and 27% lived in German-speaking and 
French-speaking municipalities, respectively. Sixty-seven 
per cent of included girls lived in a canton where school-
based vaccination was available in one or more schools 
(table 2).
spatial variability
Model 1 showed considerable spatial variation of HPV 
uptake at the municipal level (top panel, figure 2). 
Including a random effect term at the cantonal level 
(Model 2) showed that about 63% of this variation 
is explained by cantonal differences (middle panel, 
figure 2). Additionally, including covariates further 
accounted for much of the spatial variation (Model 3): 
about 88% of the spatial variation (at the municipal level) 
is explained by cantonal differences and the considered 
covariates (bottom panel, figure 2).
Model selection
Of the fitted models 1–7, the model with the smallest 
DIC was the full model (model 3, DIC=11 419) (table 1). 
Results from the univariable models (model 8), the fully 
adjusted logit (model 7) and the full model (model 3) 
are shown in figure 3 and in more detail in the online 
supplementary table 3. The association of individual 
covariates (model 8) becomes weaker after adjusting for 
all covariates (model 7) and additionally including the 
random effects (model 3). We observed persistent strong 
associations for nationality, political opinion, availability 
of school-based HPV vaccination and survey period.
Associations between vaccination uptake and covariates
Availability of school-based vaccination delivery in a canton 
was strongly associated with higher vaccination uptake 
(figure 3 and online supplementary table 3, OR from full 
model 2.51; 95% credible interval 1.77 to 3.56). Living in 
a municipality in the lowest quartile of acceptance of the 
referendum on the revision of the epidemic law was associ-
ated with reduced uptake (OR 0.61; 95% credible interval 
0.50 to 0.73) and living in a municipality in the highest 
quartile was associated with increased uptake (OR 1.22; 
95% credible interval 0.99 to 1.50). These covariates were 
strongly correlated; only 40% of girls living in municipali-
ties with low acceptance of the vote lived in a canton with 
school-based vaccination, compared with 85% of girls 
from municipalities with high acceptance (see online 
supplementary figure 8).
Vaccination uptake was higher in municipalities in the 
lowest Swiss SEP quartile (OR 1.18; 95% credible interval 
1.00 to 1.38) and among non-Swiss residents (OR 1.23; 
95% credible interval 1.09 to 1.39). Vaccination uptake 
increased over the three periods of the cross-sectional 
surveys (OR 1.22; 95% credible interval 1.07 to 1.38 and 
OR 1.58; 95% credible interval 1.38 to 1.81 for 2011–2013 
and 2014–2016, respectively). In the full model, there 
was no evidence that uptake differed between municipal-
ities in high (highest quartile) and medium (second and 
third quartile) levels of SEP (OR highest quartile 0.93; 
95% credible interval 0.78 to 1.10).
In univariable models, living in a French-speaking 
municipality was associated with higher vaccination 
uptake while living in a rural or protestant municipality 
was associated with lower uptake (figure 3 and online 
supplementary table 3). However, there was little evidence 
that these factors were associated with HPV vaccine uptake 
after adjusting for other covariates and accounting for 
cantonal and municipal-level differences (full model). 
Language region was highly correlated with both school-
based vaccination (school-based vaccination was available 
in all French-speaking cantons) and vote results (<1% of 
girls from French-speaking regions lived in municipalities 
Figure 1 Crude human papillomavirus (HPV) vaccination uptake per district in Switzerland over all survey periods (2009–2016). 
The vaccination uptake was computed by dividing the number of girls who received at least one dose of HPV vaccine with 
the total number of responding girls from the corresponding district. White areas represent cantons for which we did not get 
authorisation to analyse the data.
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with lowest acceptance of the referendum, compared 
with 38% for German-speaking regions).
The results of our sensitivity analysis strengthened the 
validity of our findings for most of the covariates. Imputing 
vaccine uptake in non-respondents using extreme 
assumptions (all vaccinated or all non-vaccinated) did not 
substantially change the estimated OR for most covari-
ates (see online supplementary material, section 3 and 
table 4,5). The estimated ORs did change for nationality 
and survey period; non-Swiss individuals were over-rep-
resented among non-respondents, and the last survey 
period had a higher proportion of non-respondents 
compared with the other two survey periods. For school-
based vaccination, the ORs were slightly reduced for both 
extreme assumptions when compared with the full model, 
but remained high (OR 1.94; 95% credible interval 1.34 
Table 2 Characteristics of the included participants of the 
Swiss National Vaccination Coverage Survey on human 
papillomavirus 
Covariates Proportion Total N
Vaccination
uptake 
(proportion) N
Nationality
  Unknown 0.12 1051 0.66 690
  Swiss 0.70 6254 0.51 3199
  Non-Swiss 0.19 1660 0.60 991
Urbanisation levels*
  Rural 0.17 1549 0.49 758
  Semi-urban 0.18 1650 0.53 868
  Urban 0.64 5766 0.56 3254
SEP quartile*
  Lowest SEP 0.26 2364 0.59 1401
  Baseline SEP 0.53 4722 0.53 2504
  Highest SEP 0.21 1879 0.52 975
Political opinion*
  Lowest acceptance 0.24 2177 0.38 815
  Baseline acceptance 0.59 5285 0.59 3096
  Highest acceptance 0.17 1503 0.64 969
Religious denomination*
  No majority 0.46 4099 0.57 2326
  ≥50% Protestant 0.11 973 0.45 435
  ≥50% Catholic 0.43 3893 0.54 2119
Language region*
  German speaking 0.66 5941 0.49 2930
  French speaking 0.27 2437 0.68 1658
  Italian speaking 0.07 587 0.5 292
School-based vaccination†
  No 0.33 2936 0.37 1084
  Yes 0.67 6029 0.63 3796
Survey period†
  2009–2010 0.23 2064 0.46 945
  2011–2013 0.42 3793 0.54 2039
  2014–2016 0.35 3108 0.61 1896
*Municipality level covariate.
†Cantonal level covariate.
HPV, human papillomavirus; SEP, socioeconomic position.
Figure 2 Spatial variation of human papillomavirus (HPV) 
vaccination uptake in Switzerland at the municipal level. 
Top panel: spatial variation accounting only for correlation 
between neighbouring municipalities (Model 1, Besag-York-
Mollié model, BYM unadjusted); middle panel: remaining 
spatial variation after adjusting for cantonal differences 
(Model 2, BYM cantonal); bottom panel: remaining spatial 
variation after adjusting for cantonal differences and 
covariates (Model 3, full). Shown are the differences from 
the mean on the log odds scale. Municipalities with no 
information about HPV vaccination uptake borrow information 
from the first-order neighbouring municipalities. White areas 
represent cantons for which we did not get authorisation to 
analyse the data.
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to 2.83 and OR 2.02; 95% credible interval 1.47 to 2.81, 
respectively). Accounting for different sampling methods 
in the full model resulted in similar estimates of OR for 
the covariates (see online supplementary table 5).
dIsCussIOn
This spatial analysis of cross-sectional survey data found 
that cantonal differences and included covariates 
explained up to almost 90% of municipality-level varia-
tion in HPV vaccination uptake among girls in Switzer-
land. Availability of school-based vaccination delivery 
was strongly associated with increased HPV vaccination 
uptake and low municipal-level acceptance of a popular 
vote about the revision of the epidemic law, which 
included strengthening of vaccination promotion, was 
strongly associated with decreased uptake. Uptake of 
HPV vaccination increased over the three survey periods 
from 2009 to 2016.
The main strength of our study was the availability of 
survey data based on written vaccination records from 
cantons that included more than 90% of the Swiss popula-
tion during the roll-out of HPV vaccination programmes 
from 2009 to 2016. We were able to include a wide range 
of covariates at individual, municipal and cantonal levels. 
Furthermore, our analysis accounted for spatial autocor-
relation, which could result in inaccurate associations if 
ignored.28 46 Our study has some limitations. First, the 
five cantons that did not participate in this study all come 
from the German-speaking part of Switzerland. We do not 
expect this to have biased our results markedly because 
vaccination uptake in the non-participating cantons 
was similar to that of other German-speaking cantons 
(see online supplementary table 1). Second, the survey 
sampling methods and response rates differed between 
cantons. Our sensitivity analysis showed that the effect of 
covariates remained similar after accounting for differ-
ences in sampling methods. Third, our findings might 
have been affected by selection bias. If parents of vacci-
nated girls were more likely to respond to the survey, HPV 
vaccine uptake levels might be overestimated. However, 
even under extreme assumptions about vaccine uptake 
in non-respondents, the association of the covariates with 
vaccination uptake remained similar (except for nation-
ality and survey period which had large differences in 
response rates). Fourth, the municipal-level covariates 
were based on data collected in the national census from 
2000, before HPV vaccination programmes began. We 
do not expect this to have affected our study because the 
composition of communities in Switzerland according 
to factors such as religion and SEP show little variation 
over time.47 Lastly, the most recent information about the 
organisation of cantonal HPV vaccination programmes, 
on which we based our analysis, was a report published in 
2009. The decision to implement school-based vaccina-
tion could be taken at regional, cantonal or school health 
department level and aspects of the programmes in some 
cantons might have changed since then. The report 
only stated whether school-based vaccination delivery 
Figure 3 OR and 95% credible intervals for being vaccinated for human papillomavirus. The full model (model 3) is adjusted 
for all covariates and includes random effect terms to account for cantonal and municipal differences in uptake and spatial 
autocorrelation at the municipality level. The adjusted model (model 7) includes all covariates without any random effect terms. 
The univariable model (model 8) includes each covariate individually at a time without random effect terms.
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was available, but not in how many schools. Despite this 
limitation, we found this variable to be strongly associated 
with uptake.
To our knowledge, our study is the first analysis of spatial 
variation in HPV vaccination uptake in a country using 
outcome data at the individual level and adjusting for 
spatial autocorrelation. A systematic review of 25 studies 
of factors associated with HPV vaccine uptake, published 
up to 2011, found that most were cross-sectional studies 
from a single or limited number of states in the USA.14 
The studies typically included factors at the individual 
level and controlled for no or a limited number of poten-
tial confounders. The review highlighted that the highest 
levels of vaccination uptake came from studies with school-
based programmes, which corroborates our finding that 
availability of school-based vaccination delivery is asso-
ciated with higher uptake. We found three studies that 
used spatial autocorrelation models, published since 
2011, all from limited geographical areas in the USA. 
The first targeted uninsured and publicly insured chil-
dren in North Carolina,17 the second used data from an 
internet survey from the Twin Cities Metropolitan Area 
of Minnesota22 and the third was based on seven Minne-
sota counties.16 In these studies, substantial spatial vari-
ation remained after adjusting for their covariates. Our 
study covered the majority of a whole country and the full 
model explained almost all small-scale spatial variation. 
Two studies that examined geographical variation in HPV 
vaccination uptake according to voting patterns, in the 
Netherlands11 and the USA,15 found lower HPV vaccine 
uptake in areas that elected religious or conservative 
parties. An advantage of our study is that we used voting 
data from a referendum that was more closely linked to 
people’s attitudes towards vaccination than voting for a 
political party in general.
We found that girls living in municipalities with the 
lowest percentage acceptance of a vote to revise an 
epidemic law were less likely to be vaccinated. Some18 20 21 27 
but not all11 16 19 20 23–26 studies have found an inverse asso-
ciation between SEP (or poverty based on income) and 
HPV vaccine uptake. This discrepancy between studies 
might be due to differences in national healthcare and 
health insurance systems. We found that girls living in 
municipalities in the lowest quartile of Swiss SEP were 
more likely to receive HPV vaccination than in municipal-
ities in the middle quartiles in the univariable, but not the 
multivariable analysis. Our finding that non-Swiss girls 
were more likely to be vaccinated than Swiss girls could 
mean that people with family origins outside Switzer-
land accept vaccination more readily than Swiss people 
but it might also reflect household-level socioeconomic 
disparities that were not captured by the Swiss SEP. Since 
non-Swiss girls had a higher non-response rate, interpre-
tation should be treated with caution. Ethnicity was not 
recorded in the SNVCS and is not routinely recorded in 
Switzerland. Other studies that have considered ethnicity 
report lower levels of HPV vaccine uptake in girls from 
non-white ethnic groups.14 We think that our findings 
about the importance of school-based vaccination delivery 
and attitudes towards vaccination can be applied to other 
high-income countries in which HPV vaccination is 
covered by health insurance, but where HPV vaccination 
coverage could be improved. The cultural, linguistic and 
geographic heterogeneity of the Swiss population means 
that it shares characteristics with a range of different 
settings.
The findings of our study support the hypothesis that there 
is interplay between people’s attitudes about vaccination, 
the availability of vaccination services and the probability of 
an individual girl receiving HPV vaccination. The best-fit-
ting model included a random effect at the cantonal level 
and, together with selected covariates, explained almost all 
small-scale spatial variation in HPV vaccine uptake. Cantons 
have considerable autonomy in providing health services 
and represent a contextual factor for vaccine accessibility. 
Vaccine scepticism in a community, in turn, could impact 
the political outcome of decision makers and hence affect 
vaccination policies. Our findings do not necessarily repre-
sent causal associations because of the ecological nature of 
the associations and the cross-sectional nature of our study 
design. The strong association between HPV vaccination 
uptake and patterns of voting about vaccination laws at the 
municipality level are, however, consistent with the sugges-
tion that scepticism or opposition to vaccination could 
influence decisions of parents and their daughters to get 
vaccinated. A nationally representative Swiss survey found 
that fear of side effects and general opposition to vaccina-
tion were two of the main reasons that participants gave 
for not being vaccinated against HPV.48 The vote results 
were also strongly correlated with the availability of school-
based vaccination. This relation might indicate how indi-
viduals shape their community, thereby influencing health 
services and affecting health outcomes. Thus, the difficulty 
to achieve higher levels of HPV vaccination uptake in areas 
with high levels of vaccine scepticism result not only from 
vaccine refusal, but also from a lack of easy access to vaccina-
tion such as through school-based delivery.
We conducted a multilevel spatial analysis to identify 
the factors that are associated with the spatial variation in 
HPV vaccination uptake in Switzerland. Our study high-
lights the importance of taking into account spatial auto-
correlation and covariates at different spatial levels. Our 
results support the importance of an interplay between 
regional contextual factors and vaccine scepticism in 
determining HPV vaccination uptake. Our study suggests 
that higher levels of HPV vaccination could be achieved 
by efforts to mitigate vaccine scepticism, which might 
then permit broader use of school-based delivery of HPV 
vaccination.
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